Clinical Trial Update: Study With T-cel Receptor Gene Therapy in Metastatic Melanoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating a T-cell receptor gene therapy for metastatic melanoma, including stage IV skin melanoma and ocular melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Ocular Melanoma
• Skin Melanoma

Drugs mentioned

• T-cell receptor gene therapy

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Stage IV Skin Melanoma, Eye; Melanoma | Phase 1, Phase 2 | Status: UNKNOWN